Physician profile
Anja S Panetta
NPI 1083866776
$4,042.81
in general payments reported to CMS, 2019-2025
19 companies · $61.98 in 2025
The $61.98 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,477 · 2022: $1,088 · 2023: $365 · 2024: $50.55 · 2025: $61.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $477.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,425.20 | 2021-2025 | |
| Pfizer INC. | $435.04 | 2021-2022 | |
| Epi Health, LLC | $353.72 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $338.82 | 2021-2022 | |
| Vyne Pharmaceuticals INC. | $242.28 | 2021 | |
| Leo Pharma INC. | $227.03 | 2021-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $209.77 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $158.52 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $145.28 | 2021-2022 | |
| Allergan, INC. | $127.84 | 2022 | |
| Lilly USA, LLC | $76.89 | 2021-2022 | |
| Biofrontera INC. | $51.41 | 2021 | |
| Janssen Biotech, INC. | $47.90 | 2021 | |
| Genzyme Corporation | $45.14 | 2021-2022 | |
| Amgen INC. | $43.47 | 2021-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermira, INC. | $42.38 | 2021 | |
| Incyte Corporation | $29.23 | 2021 | |
| Ucb, INC. | $26.27 | 2021 | |
| Galderma Laboratories, L.P. | $16.62 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anja Panetta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.